Skip to content
Adam Torkildson – Lifestyle
Author:
Arcutis Biotherapeutics, Inc.
Arcutis to Report First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026
April 15, 2026
Arcutis Management to Present at the 25th Annual Needham Virtual Healthcare Conference
March 31, 2026
Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data with ZORYVE® (roflumilast) Cream 0.05% for Treatment of Mild-to-Moderate Atopic Dermatitis in Children Ages 2–5 in Pediatric Dermatology
March 10, 2026
←
Previous Page
1
2
3